p53 and TIGAR regulate cardiac myocyte energy homeostasis under hypoxic stress

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 299, Issue 6, 2010, Pages

  Kimata, Masaki ^a   Matoba, Satoaki ^a   Iwai Kanai, Eri ^a   Nakamura, Hideo ^a   Hoshino, Atsushi ^a   Nakaoka, Mikihiko ^a   Katamura, Maki ^a   Okawa, Yoshifumi ^a   Mita, Yuichiro ^a   Okigaki, Mitsuhiko ^a   Ikeda, Koji ^a   Tatsumi, Tetsuya ^a   Matsubara, Hiroaki ^a  

^a KYOTO PREFECTURAL UNIVERSITY   (Japan)

Author keywords

Glycolysis; Hypoxia; Metabolism; Mitochondria; TP53 induced glycolysis and apoptosis regulator

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; DEOXYGLUCOSE; FRUCTOSE 2,6 BISPHOSPHATE; PROTEIN P53; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; BIOENERGY; CELL DEATH; CELL ENERGY; CONTROLLED STUDY; ENERGY METABOLISM; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; GLUCOSE HOMEOSTASIS; GLUCOSE UTILIZATION; GLYCOLYSIS; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HYPOXIA; MITOCHONDRIAL MEMBRANE POTENTIAL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TP53 INDUCED GLYCOLYSIS AND APOPTOSIS REGULATOR GENE; WILD TYPE;

ADENOSINE TRIPHOSPHATE; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL HYPOXIA; CELLS, CULTURED; DEOXYGLUCOSE; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; GLYCOLYSIS; HOMEOSTASIS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; PHOSPHOCREATINE; PHOSPHOFRUCTOKINASE-2; PROTEINS; RATS; RNA INTERFERENCE; STRESS, PHYSIOLOGICAL; TIME FACTORS; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 78649753882     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00250.2010     Document Type: Article

References (38)

1. Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, Bartrons R, Gottlieb E, Vousden KH. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126: 107-120, 2006.
2. Bialik S, Geenen DL, Sasson IE, Cheng R, Horner JW, Evans SM, Lord EM, Koch CJ, Kitsis RN. Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53. J Clin Invest 100: 1363-1372, 1997.
3. Ceddia RB, Somwar R, Maida A, Fang X, Bikopoulos G, Sweeney G. Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells. Diabetologia 48: 132-139, 2005.
4. Cohen MV, Yang XM, Downey JM. The pH hypothesis of postconditioning: staccato reperfusion reintroduces oxygen and perpetuates myocardial acidosis. Circulation 115:1895-1903, 2007.
5. Cook SA, Sugden PH, Clerk A. Regulation of bcl-2 family proteins during development and in response to oxidative stress in cardiac myocytes: association with changes in mitochondrial membrane potential. Circ Res 85: 940-949, 1999.
6. Fliss H, Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ Res 79: 949-956, 1996.
7. Folmes KD, Witters LA, Allard MF, Young ME, Dyck JR. The AMPK gamma1 R70Q mutant regulates multiple metabolic and growth pathways in neonatal cardiac myocytes. Am J Physiol Heart Circ Physiol 293: H3456-H3464, 2007.
8. Halestrap AP, Clarke SJ, Javadov SA. Mitochondrial permeability transition pore opening during myocardial reperfusion-a target for cardioprotection. Cardiovasc Res 61: 372-385, 2004.
9. Halestrap AP, Pasdois P. The role of the mitochondrial permeability transition pore in heart disease. Biochim Biophys Acta 1787: 1402-1415, 2009.
10. Ingwall JS, Weiss RG. Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ Res 95: 135-145, 2004.
11. Inserte J, Barba I, Hernando V, Abellán A, Ruiz-Meana M, Rodríguez-Sinovas A, Garcia-Dorado D. Effect of acidic reperfusion on prolongation of intracellular acidosis and myocardial salvage. Cardiovasc Res 77: 782-790, 2008.
12. Kannel WB. Incidence and epidemiology of heart failure. Heart Fail Rev 5: 167-173, 2000.
13. Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, Chernov MV, Gudkov AV. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285: 1733-1737, 1999.
14. Lee L, Horowitz J, Frenneaux M. Metabolic manipulation in ischaemic heart disease, a novel approach to treatment. Eur Heart J 25: 634-641, 2004.
15. Lee Y, Gustafsson AB. Role of apoptosis in cardiovascular disease. Apoptosis 14: 536-548, 2009.
16. Li H, Jogl G. Structural and Biochemical Studies of TIGAR (TP53-induced glycolysis and apoptosis regulator). J Biol Chem 284: 1748-1754, 2009.
17. Liao R, Jain M, Cui L, D'Agostino J, Aiello F, Luptak I, Ngoy S, Mortensen RM, Tian R. Cardiac-specific over expression of GLUT1 prevents the development of heart failure attributable to pressure overload in mice. Circulation 106: 2125-2131, 2002.
18. Long X, Boluyt MO, Hipolito ML, Lundberg MS, Zheng JS, O'Neill L, Cirielli C, Lakatta EG, Crow MT. p53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes. J Clin Invest 99: 2635-2643, 1997.
19. Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS, Stanley WC. Myocardial fatty acid metabolism in health and disease. Physiol Rev 90: 207-258, 2010.
20. Luptak I, Yan J, Cui L, Jain M, Liao R, Tian R. Long-term effects of increased glucose entry on mouse hearts during normal aging and ischemic stress. Circulation 116: 901-909, 2007.
21. Mano A, Tatsumi T, Shiraishi J, Keira N, Nomura T, Takeda M, Nishikawa S, Yamanaka S, Matoba S, Kobara M, Tanaka H, Shirayama T, Takamatsu T, Nozawa Y, Matsubara H. Aldosterone directly induces myocyte apoptosis through calcineurin-dependent pathways. Circulation 110: 317-323, 2004.
22. Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, Gavrilova O, Hurley PJ, Bunz F, Hwang PM. p53 regulates mitochondrial respiration. Science 312: 1650-1653, 2006.
23. Matsunaga S, Okigaki M, Takeda M, Matsui A, Honsho S, Katsume A, Kishita E, Che J, Kurihara T, Adachi Y, Mansukhani A, Kobara M, Matoba S, Tatsumi T, Matsubara H. Endothelium-targeted overexpression of constitutively active FGF receptor induces cardioprotection in mice myocardial infarction. J Mol Cell Cardiol 46: 663-673, 2009.
24. Matsusaka H, Ide T, Matsushima S, Ikeuchi M, Kubota T, Sunagawa K, Kinugawa S, Tsutsui H. Targeted deletion of p53 prevents cardiac rupture after myocardial infarction in mice. Cardiovasc Res 70: 457-465, 2006.
25. McClintock DS, Santore MT, Lee VY, Brunelle J, Budinger GR, Zong WX, Thompson CB, Hay N, Chandel NS. Bcl-2 family members and functional electron transport chain regulate oxygen deprivation-induced cell death. Mol Cell Biol 22: 94-104, 2002.
26. Neubauer S. The failing heart: an engine out of fuel. N Engl J Med 356: 1140-1151, 2007.
27. Nicolli A, Basso E, Petronilli V, Wenger RM, Bernardi P. Interactions of cyclophilin with the mitochondrial inner membrane and regulation of the permeability transition pore, and cyclosporin A-sensitive channel. J Biol Chem 271: 2185-2192, 1996.
28. Rasola A, Bernardi P. The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis. Apoptosis 12: 815-833, 2007.
29. Russell RR, Li J, Coven DL, Pypaert M, Zechner C, Palmeri M, Giordano FJ, Mu J, Birnbaum MJ, Young LH. AMP-activated protein kinase mediates ischemic glucose uptake and prevents post ischemic cardiac dysfunction, apoptosis and injury. J Clin Invest 114: 495-503, 2004.
30. Sano M, Minamino T, Toko H, Miyauchi H, Orimo M, Qin Y, Akazawa H, Tateno K, Kayama Y, Harada M, Shimizu I, Asahara T, Hamada H, Tomita S, Molkentin JD, Zou Y, Komuro I. p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 446: 444-448, 2007.
31. Shizukuda Y, Matoba S, Mian OY, Nguyen T, Hwang PM. Targeted disruption of p53 attenuates doxorubicin-induced cardiac toxicity in mice. Mol Cell Biochem 273: 25-32, 2005.
32. Sliwa K, Damasceno A, Mayosi BM. Epidemiology and etiology of cardiomyopathy in africa. Circulation 112: 3577-3583, 2005.
33. 2 respiration, reduced ATP utilization, and inducible fumarate respiration. Am J Physiol Cell Physiol 295: C29-C37, 2008.
34. Tatsumi T, Shiraishi J, Keira N, Akashi K, Mano A, Yamanaka S, Matoba S, Fushiki S, Fliss H, Nakagawa M. Intracellular ATP is required for mitochondrial apoptotic pathways in isolated hypoxic rat cardiac myocytes. Cardiovasc Res 52: 428-440, 2003.
35. Tuunanen H, Engblom E, Naum A, Någren K, Scheinin M, Hesse B, Juhani Airaksinen KE, Nuutila P, Iozzo P, Ukkonen H, Opie LH, Knuuti J. Trimetazidine, a metabolic modulator, has cardiac and extra cardiac benefits in idiopathic dilated cardiomyopathy. Circulation 118: 1250-1258, 2008.
36. Van Schaftingen E, Lederer B, Bartrons R, Hers HG. A kinetic study of pyrophosphate: fructose-6-phosphate phosphotransferase from potato tubers. Application to a microassay of fructose 2,6-bisphosphate. Eur J Biochem 129: 191-195, 1982.
37. Webster KA, Discher DJ, Kaiser S, Hernandez O, Sato B, Bishopric NH. Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53. J Clin Invest 104: 239-252, 1999.
38. Yan J, Young ME, Cui L, Lopaschuk GD, Liao R, Tian R. Increased glucose uptake and oxidation in mouse hearts prevent high fatty acid oxidation but cause cardiac dysfunction in diet-induced obesity. Circulation 119: 2818-2828, 2009.